AACR-NCI-EORTC news: Japanese research team presents new hypoxic cell radiosensitizing agent Nov. 25, 1999 No Comments
Mount Sinai investigators describe novel apoptosis-inducing agent at scientific forum Nov. 25, 1999 No Comments
Valentis initiates phase IIa trial of IFN-alpha gene medicine in angiosarcoma Nov. 25, 1999 No Comments
Combination therapy containing GTI-2040 shows remarkable antitumor activity Nov. 25, 1999 No Comments
More promising cancer news from AACR-NCI-EORTC: Hughes Institute presents new compounds Nov. 24, 1999 No Comments